Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

71.20 -2.33 (-3.17%)
Official Closing Price Updated: 4:15 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Illumina Wins Reddot 2021 Award: Genomic Sequencing System NextSeq 1000/2000
SOURCE: Illumina 
Via 3BL Media
Delta Defeats Bulls
Stocks tended to crash without rhyme or reason. 
Via Talk Markets
Best And Worst Performances Of The Week
Last week saw US indexes fall along with those of many European countries. However, Japan, Hong Kong, and Chinese markets all rose. 
Via Talk Markets
Illumina Partners With Arab Health in Neonatal and Pediatric Intensive Care Settings
Illumina Partners With Arab Health in Neonatal and Pediatric Intensive Care Settings 
Via News Direct
Illumina Partners With Arab Health in Neonatal and Pediatric Intensive Care Settings
SOURCE: Illumina 
Via 3BL Media
Illumina Commemorates Juneteenth
SOURCE: Illumina 
Via 3BL Media
Illumina Celebrates Pride Month
SOURCE: Illumina 
Via 3BL Media
Record-breaking Achievement at Rady Children's Institute for Genomic Medicine
SOURCE: Illumina 
Via 3BL Media
Apple And Qualcomm Lead The QQQ Higher Wednesday
U.S. indices were trading higher Wednesday as investors weigh comments from Fed Chair Powell. Strength in Apple Inc (NASDAQ: 
Via Benzinga
Topics Economy
Exposures Interest Rates
Bioinformatics Services Market Worth $5.3 Billion by 2026 - Exclusive Report by MarketsandMarkets™
The bioinformatics services market is projected to reach $5.3 Billion by 2026. Bioinformatics analysis market report provides crucial industry insights that will help your business grow. 
Via SBWire
Illumina, Grail Merger Faces Full-Scale European Probe Amid Antitrust Concerns: Reuters
The proposed $8 billion merger between liquid biopsy firm Grail Inc and cancer blood screening firm Illumina Inc (NASDAQ: ILMN) has met with nothing but flack... 
Via Benzinga
Is Illumina a Buy?
Illumina has gained almost 29% this year and could be headed higher. 
Via The Motley Fool
Illumina to Announce Second Quarter 2021 Financial Results on Thursday, August 5, 2021
From Illumina, Inc.
Via Business Wire
Revolutionizing Forensics with Illumina’s Next-Generation Sequencing Technology
Othram, Inc. and the NovaSeq help convert more cases from cold to solved 
Via News Direct
Topics Death
Exposures Criminal Death Legal
Revolutionizing Forensics with Illumina’s Next-Generation Sequencing Technology
SOURCE: Illumina 
Via 3BL Media
Topics Death
Exposures Criminal Death Legal
3 Large-Cap Growth Stocks to Add to Your Portfolio This Summer
Even though investors rotated away from expensive growth stocks earlier this year, select growth stocks have been experiencing strong rebounds and in some instances are making new highs. 
Via Talk Markets
Why Illumina Was Up 17% in June
The company's liquid-biopsy spinoff can reportedly detect early-stage cancer in blood samples. 
Via The Motley Fool
Illumina and LetsGetChecked Collaborate on Surveillance Projects to Detect Covid-19 Variants
SOURCE: Illumina 
Via 3BL Media
Exposures COVID-19
Congratulations to Illumina on Winning the Athena STEM Corporate Pinnacle Award
SOURCE: Illumina 
Via 3BL Media
Topics Economy Supply Chain
Exposures Economy Supply Chain
5 Top Stocks for July
These stocks could bring some heat to your portfolio. 
Via The Motley Fool
How Illumina Creates a Culture of Care through Robust Employee Benefits and Wellness Programs
SOURCE: Illumina 
Via 3BL Media
CSR Q&A With Illumina's Chief Financial Officer
SOURCE: Illumina 
Via 3BL Media
Topics Climate Change Supply Chain
Exposures COVID-19 Climate Product Safety
Single-Cell Analysis Market Worth $5.6 Billion by 2025 – Spectrophotometers Play an Integral Role in the Life Sciences Industry
The single-cell analysis market is projected to reach USD 5.6 billion by 2025 from USD 2.1 billion in 2019, at a CAGR of 17.8% 
Via SBWire
CSR Q&A With Illumina's Chief Financial Officer
SOURCE: Illumina 
Via 3BL Media
Topics Climate Change Supply Chain
Exposures COVID-19 Climate Product Safety
Illumina and Next Generation Genomic Launch Expanded NIPT in Thailand
SOURCE: Illumina 
Via 3BL Media
Illumina Supports Rockefeller Foundation with Global Pathogen Sequencing Collaboration
SOURCE: Illumina 
Via 3BL Media
Agrigenomics Market Worth $5.3 Billion by 2026
Northbrook, IL -- (SBWIRE) -- 06/17/2021 -- Agrigenomics Market by Application (Crops and Livestock), Sequencer Type (Sanger Sequencing, Illumina HiSeq Family, PacBio Sequencer, SOLiD Sequencer),... 
Via SBWire
Agrigenomics Market Will Hit Big Revenues In Future | Key Players are Eurofins Scientific, Agilent Technologies, Inc., LGC Limited, Illumina, Inc., and Zoetis Inc.
Via AB Newswire
Illumina Announces the Thirteenth Agricultural Greater Good Grant Winner
SOURCE: Illumina 
Via 3BL Media
Has Illumina Lost Its Shine?
Cathie Wood lost her conviction and dumped the stock. Can Illumina get back on track? 
Via The Motley Fool
Topics Regulatory Compliance
Exposures Legal Regulatory
< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.